Programme 2022

---

8.30                   Registration, networking at the exhibition and partnering meetings

8.55                   Welcome and introduction
                          Johan Rockberg, moderator

9.00                   Development of a DNA-based vaccine against SARS-CoV-2 – a collaborative effort between academia, healthcare, and industry
                           Lars Frelin, Associate Professor in Virology, Karolinska Institutet

9.25                   How to overcome the challenges and pitfalls of taking a biological from pre-clinical to clinical development
                           Ola Tuvesson, Head of Development, NorthX Biologics

9.50                   IVT RNA vaccine QC and CGT tools
                           Ossian Saris, Market Specialist - Europe, Agilent Technologies

10.15                 Coffee, networking at the exhibition and partnering meetings

11.00                 Pathways to speed up product CMC development for the first-in-human clinical trials
                           Paresh Vadgama, Fellow Scientist, Product Development, Catalent Biologics
 

11.25                 Safe implementation Pre-Use Post-Sterilization Integrity Test (PUPSIT) on final sterilising grade filters in single-use assemblies
                           Alexandra Guerra, Principal Scientist, Pall Corporation

11.50                 Virtual assessment of intestinal absorption of biological molecules
                           Christel Bergström, Professor in Molecular Pharmaceutics, Uppsala University

12.15                 Lunch, networking at the exhibition and partnering meetings

13.10                 How Modular & Pod-ular provide key leverage to a successful, rapid scale out deployment
                           Andrew Dell, President, KeyPlants Inc

13.35                 Smart platform for fast development of small-scale integrated continuous downstream processes
                           Bernt Nilsson, Professor in Chemical Engineering, Lund University

14.00                 Process understanding through down-scale modeling
                           Marie Svensson, Manager New Technology, Pfizer Biotech Sweden

14.25                 Coffee, networking at the exhibition and partnering meetings

15.05                 GeneNova – platforms for next generation gene therapy biologics
                           Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology

15.30                 Panel discussion: Vaccine platforms, gene therapy and precision health – where are we today and what will we need in the future?
                           Marie Svensson, Manager New Technology, Pfizer Biotech Sweden
                           Ola Tuvesson, Head of Development, NorthX Biologics
                           Ossian Saris, Market Specialst - Europe, Agilent Technologies
                           Paresh Vadgama, Fellow Scientist, Product Development, Catalent Biologics
                          

15.55                 Summary and conclusion

16.00                 Drinks & refreshments reception and celebrations for Life Science Sweden’s 20th anniversary